Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Impact of the Omics-Based Biomarkers on the Fluvoxamine’s Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder
1
x
$
30.00
Divalproex in the Treatment of Bipolar Disorder
1
x
$
30.00
Oral Antipsychotic Versus Long- Acting Injections Antipsychotic in Schizophrenia Spectrum Disorder: a Mirror Analysis in a Real-World Clinical Setting
1
x
$
30.00
Characterizing the Effects of Quetiapine in Military Post-Traumatic Stress Disorder
1
x
$
30.00
Psychopharmacology Bulletin VOL 48 No. 4, 2018 - Full Issue Stacked PDF
1
x
$
90.00
Psychopharmacology Bulletin VOL 49 No. 2, 2019 - Full Issue Stacked PDF
1
x
$
90.00
View Cart
Checkout
Home
antidepressant agents
You cannot add another "Psychopharmacology Bulletin VOL 48 No. 4, 2018 - Full Issue Stacked PDF" to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Psychopharmacology Bulletin VOL 48 No. 4, 2018 – Full Issue Stacked PDF
$
90.00
Add to cart
Details
Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial
$
30.00
Add to cart
Details
Developing an IV Ketamine Clinic for Treatment-Resistant Depression: a Primer
$
30.00
Add to cart
Details
Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies
$
30.00
Add to cart
Details
Page load link
Go to Top
